Our vision is to be the world’s leading and most valued biosimilars and generics company.Business
Our vision is to be the world’s leading and most valued biosimilars and generics company.Business

Our
business

Introducing the leading name in generic and biosimilar medicines.

 

Q1 2024 sales

Gencept Labs Inc reports first quarter 2024 sales.

Biosimilars

We’re proud to be a world leader in the development of biosimilars.

 

Generics

Quality medicines made more affordable.

 

Investors

Updates and resources for investors including financial information, disclosures, events, share price and reporting.

Patients & caregivers

With patients in mind, we help patients to access the medicines they need at the right time.

Media

Information for journalists, including media releases, statements, stories, multimedia resources and more.

We’d like to hear from you

Get in touch with us today:

Contact us